1-5 of 5
William D. Erwin
Close
Sort by
Journal Articles

Durability Results of Non-Myeloablative (NMA) Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed Follicular Lymphoma: 17- Year Experience

Issa F. Khouri, Denái R. Milton, Celina Ledesma, William D Erwin, MS, Elias J. Jabbour, MD, Gheath Alatrash, DO, PhD, Paolo Anderlini, MD, Qaiser Bashir, MD MBBS, Stefan O. Ciurea, Jin S Im, MD PhD, David Marin, MD, Rohtesh S. Mehta, MD MPH, MS, Jeffrey J. Molldrem, MD, Amanda L. Olson, MD, Betul Oran, MD MS, Uday Popat, MD, Muzaffar H. Qazilbash, MD, Gabriela Rondon, MD, Richard E Champlin, MD, L. Jeffrey Medeiros, MD, Alison Gulbis
Journal: Blood
Blood (2018) 132 (Supplement 1): 4651.
https://doi.org/10.1182/blood-2018-99-117767
Published: 2018
Journal Articles

In-Vivo Purging with Rituximab (R) Followed By Z/BEAM Vs BEAM/R Autologous Stem Cell Conditioning for Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) Patients (pts): Mature Results from a Combined Analysis of 3 Trials

Issa F. Khouri, Dawen Sui, Francesco Turturro, MD, William D Erwin, Roland L Bassett, Jr., Martin Korbling, Rosamar Valverde, Sairah Ahmed, Amin M. Alousi, MD, Paolo Anderlini, Qaiser Bashir, MD, Stefan O. Ciurea, MD, Betul Oran, MD, Amanda Olson, Uday R. Popat, MD, Krina K Patel, Muzaffar H. Qazilbash, MD, Michelle A. Fanale, Luis E. Fayad, MD, Loretta Nastoupil, MD, Jason R Westin, MD, Alison M Gulbis, L. Jeffrey Medeiros, Ken H. Young, Aaron Jessop
Journal: Blood
Blood (2015) 126 (23): 3192.
https://doi.org/10.1182/blood.V126.23.3192.3192
Published: 2015
Journal Articles

Nonmyeloablative allogeneic transplantation with or without 90 yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results

Clinical Trials & Observations
Issa F. Khouri, Rima M. Saliba, William D. Erwin, Barry I. Samuels, Martin Korbling, L. Jeffrey Medeiros, Rosamar Valverde, Amin M. Alousi, Paolo Anderlini, Qaiser Bashir, Stefan Ciurea, Alison M. Gulbis, Marcos de Lima, Chitra Hosing, Partow Kebriaei, Uday R. Popat, Nathan Fowler, Sattva S. Neelapu, Felipe Samaniego, Richard E. Champlin, Homer A. Macapinlac
Journal: Blood
Blood (2012) 119 (26): 6373–6378.
https://doi.org/10.1182/blood-2012-03-417808
Published: 2012
Journal Articles

Zevalin®/BEAM/Rituximab vs BEAM/Rituximab and Autologous Stem Cell Transplantation (ASCT) for Relapsed Chemosensitive Diffuse Large B-Cell Lymphoma (DLBCL): Impact of the IPI and PET Status.

Amin M. Alousi, MD, Chitra Hosing, M.D., Rima M. Saliba, PhD., Rosamar B. Valverde, BSN, Farzaneh Maadani, BS, Martin Korbling, M.D., Grace J. Okoroji, MS, Luis E. Fayad, M.D., Anne M. Stachowiak, BS, William D. Erwin, MS, Paolo Anderlini, M.D., Marcos J. de Lima, M.D., Sergio A. Giralt, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Naoto T. Ueno, M.D., Peter W. McLaughlin, M.D., Barbara Pro, M.D., Michael Wang, M.D., Alma Rodriguez, M.D., Fredrick B. Hagemeister, M.D., Homer A. Macapinlac, M.D., Donald A. Podoloff, M.D., Richard E. Champlin, M.D., Issa F. Khouri, M.D.
Journal: Blood
Blood (2007) 110 (11): 620.
https://doi.org/10.1182/blood.V110.11.620.620
Published: 2007
Journal Articles

Efficacy and Safety of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan in Autologous and Nonmyeloablative Stem Cell Transplantation (NST) for Relapsed Non-Hodgkin’s Lymphoma (NHL).

Issa F. Khouri, MD, Rima M. Saliba, PHD, Chitra Hosing, MD, Rosamar Valverde, RN, William D. Erwin, MS, Luis Fayad, MD, Farzaneh Maadani, BS, Martin J. Korbling, MD, Grace-Julia Okoroji, MS, Anne M. Stachowiak, BS, Barry I. Samuels, MD, Paolo Anderlini, MD, Daniel R. Couriel, MD, Marcos de Lima, MD, Sergio Giralt, MD, Uday Popat, MD, Partow Kebriaei, MD, Naoto T. Ueno, MD, Muzaffar H. Qazilbash, MD, Peter W. McLaughlin, MD, Fredrick B. Hagemeister, MD, Anas Younes, MD, Donald A. Podoloff, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2006) 108 (11): 315.
https://doi.org/10.1182/blood.V108.11.315.315
Published: 2006